D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Capri Holdings
CPRI
$2.54B
| $36.6M | 0.05% |
800,849
-2,737,133
| -77% | -$125M |
|
352
Campbell Soup
CPB
$10.1B
| $36.5M | 0.05% |
958,258
+188,228
| +24% | +$7.18M |
|
353
Coca-Cola Europacific Partners
CCEP
$41.6B
| $36.4M | 0.05% |
703,161
+303,556
| +76% | +$15.7M |
|
354
Devon Energy
DVN
$21.8B
| $36M | 0.05% |
1,140,855
-594,688
| -34% | -$18.8M |
|
355
Heron Therapeutics
HRTX
$199M
| $36M | 0.05% |
1,471,596
+417,588
| +40% | +$10.2M |
|
|
AAN.A
356
DELISTED
AARON'S INC CL-A
AAN.A
| $36M | 0.05% |
683,707
+292,529
| +75% | +$15.4M |
|
357
Pacira BioSciences
PCRX
$1.18B
| $35.9M | 0.05% |
942,444
+570,237
| +153% | +$21.7M |
|
358
Sally Beauty Holdings
SBH
$1.45B
| $35.9M | 0.05% |
1,947,697
-735,555
| -27% | -$13.5M |
|
359
Elanco Animal Health
ELAN
$9.32B
| $35.7M | 0.05% |
1,112,278
-369,971
| -25% | -$11.9M |
|
360
H&R Block
HRB
$6.97B
| $35.7M | 0.05% |
1,489,302
-527,714
| -26% | -$12.6M |
|
|
WW
361
DELISTED
WW International
WW
| $35.6M | 0.05% |
+1,766,790
| New | +$35.6M |
|
362
Abercrombie & Fitch
ANF
$4.48B
| $35.2M | 0.05% |
1,283,878
+1,070,577
| +502% | +$29.3M |
|
363
LPL Financial
LPLA
$27.2B
| $35M | 0.05% |
502,388
-36,032
| -7% | -$2.51M |
|
364
CF Industries
CF
$13.7B
| $35M | 0.05% |
855,117
+735,677
| +616% | +$30.1M |
|
365
Teck Resources
TECK
$19.1B
| $34.9M | 0.05% |
1,507,502
-1,454,607
| -49% | -$33.7M |
|
366
Timken Company
TKR
$5.37B
| $34.5M | 0.04% |
790,982
+78,200
| +11% | +$3.41M |
|
367
Wyndham Hotels & Resorts
WH
$6.71B
| $34.4M | 0.04% |
688,320
-101,516
| -13% | -$5.07M |
|
368
IAC Inc
IAC
$2.88B
| $34.3M | 0.04% |
914,625
-357,636
| -28% | -$13.4M |
|
|
SAVE
369
DELISTED
Spirit Airlines, Inc.
SAVE
| $34.2M | 0.04% |
647,867
+146,532
| +29% | +$7.75M |
|
370
Thermo Fisher Scientific
TMO
$184B
| $34.2M | 0.04% |
124,990
+94,482
| +310% | +$25.9M |
|
371
Moog
MOG.A
$6.07B
| $34.2M | 0.04% |
393,228
+40,214
| +11% | +$3.5M |
|
372
Nu Skin
NUS
$570M
| $34.1M | 0.04% |
713,303
+268,884
| +61% | +$12.9M |
|
373
Ralph Lauren
RL
$18.7B
| $34.1M | 0.04% |
263,247
+154,230
| +141% | +$20M |
|
374
SPDR Dow Jones International Real Estate ETF
RWX
$306M
| $34.1M | 0.04% |
868,904
-85,148
| -9% | -$3.34M |
|
375
Dana Inc
DAN
$2.72B
| $34.1M | 0.04% |
1,921,583
+2,439
| +0.1% | +$43.3K |
|